The concomitant use of VYVANSE and CYP2D6 inhibitors may increase the exposure of dextroamphetamine, the active metabolite of VYVANSE compared to the use of the drug alone and increase the risk of serotonin syndrome. Your healthcare provider should check for heart problems before you start lisdexamfetamine and will likely check https://jamesq616esd8.blog-a-story.com/profile